Indians Rush For O-1 Visa: Is This The Easiest Ticket To The US?
O-1 Visa: Traveling to the United States is a dream for many people in India. Many students skilled workers and talented people look for different ways to work and live in the US One visa that is getting popular among Indians is the O-1 visa. It is called the extraordinary ability visa and many people do not know much about it. Here is a simple guide to understand what the O-1 visa and how it can help you
Meaning of O-1 Visa?
The O-1 visa is a nonimmigrant visa. This visa is for people who have special talent or skill in their field. It is mostly for people in arts science sports education business or movies. The visa is given to those who can show that they are at the top in what they do. This visa allows them to live and work in the US for a certain time.
Who Can Apply for an O-1 Visa?
Many people think this visa is only for film stars or big scientists but that is not true. Many normal people with special skills can also apply. If you are an artist musician researcher chef designer writer or sportsperson, you can try for an O-1 visa. You must have proof that your work is unique and people in your field know your name. Awards media coverage published work or special positions help your case.
Why are Indians Choosing the O-1 Visa?
In the past, the H1B visa was the top choice for Indians who wanted to work in the US But now the process has become tough and many people do not get it easily So they are looking for new ways. The O-1 visa is a good option because there is no yearly cap like the H-1B. This means more chances to get it if you qualify. Also, an O-1 visa can be processed faster and you can take your family too.
Benefits of O-1 Visa
The O-1 visa has many good points. First, you can work with top companies in your field. You can also work on projects that match your skills. You can change employers if you want but you must file a new petition. You can bring your spouse and kids under an O-3 visa. They can study in the US but cannot work. You can extend your O-1 visa as long as you continue your work and have support from your employer.
How to Apply for an O-1 Visa?
You cannot apply for an O-1 visa yourself. You need a US employer or agent who will file the petition for you. They will send Form I-129 and proof that you have extraordinary ability. You must have letters from experts in your field and proof of your work. Once approved, you can attend an interview at the US embassy in India.
Final Tips for O-1 Visa Applicants
The O-1 visa is a strong option for Indians who have special talent But you must be ready with all documents. You must have a good lawyer or agent to help you collect proof. Many people do not know that good documentation makes the process smooth. Also start early so you have time to prepare well.
The O-1 visa can open doors to a bright future in the United States. If you have talent and big dreams this visa can help you live and work in the US without worry. Know your skills prepare well and use this new entry scheme to reach new heights.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
5 hours ago
- Time of India
Apollo Hospitals to hive off pharmacy, digital biz
Chennai: Apollo Hospitals Enterprise, controlled by the Prathap Reddy family, has announced a significant reorganisation where its pharmacy distribution and digital health operations will be carved out into a separate entity. This new entity, Apollo Healthtech, will seek listing on stock exchanges over the next 18 to 21 months, with current Apollo Hospitals shareholders receiving proportionate shares in the new company. The deal will create a leading omni-channel pharmacy distribution and digital health platform in India with revenues of Rs 16,300 crore ($1.9 billion), Apollo Hospitals said in a statement. Currently, Apollo Healthco (AHL) manages the wholesale pharmaceutical trading and Apollo 24/7 digital platform, while Keimed oversees wholesale distribution of pharmaceuticals and wellness products. Apollo Hospitals holds about 79% ownership in AHL, and Keimed operates as a related party to Apollo Hospitals. You Can Also Check: Chennai AQI | Weather in Chennai | Bank Holidays in Chennai | Public Holidays in Chennai The share allocation structure stipulates that for every 100 shares held in Apollo Hospitals, shareholders will receive 195.2 shares in the new company. AHL shareholders will get 89.5 shares for every 100 shares owned, while Keimed shareholders will receive 3045.2 shares for every 100 shares held. Following the completion of this demerger, both AHL and Keimed will cease to exist. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Cardiologists: 1 Teaspoon of This Before Bed Melts Belly Fat Like Crazy Hollywood News | USA Click Here Undo Under the agreement terms, Apollo Hospitals shall restrict its pharmaceutical operations exclusively to hospital-based pharmacies, refraining from any involvement in e-commerce, retail or wholesale pharmacy ventures. Veda Corporate Advisors was the exclusive financial advisor to the transaction. The new company, Apollo Healthtech, will subsequently acquire 74.5% stake in Apollo Medicals, consolidating the front-end pharmacy business. Apollo Hospitals will own a 15% stake in Apollo Healthtech and will have one nominee director on the board, the Chennai-based company said. Apollo Hospitals chairman Prathap C Reddy, said: "Today's developments mark the beginning of the next chapter of Apollo Hospitals. The omnichannel pharmacy business and integrated digital healthcare ecosystem will be a unique model to enable access to high-quality healthcare for millions of Indians."
Hindustan Times
6 hours ago
- Hindustan Times
HC slaps ₹2 lakh fine on eight tenants, says they can't oppose redevelopment of building
MUMBAI: The Bombay high court on Friday dismissed a petition filed by eight tenants who tried to stall the redevelopment of a dangerously dilapidated building in Malad West. The court fined them ₹ 2 lakh each and reiterated that the property owner has the right to get his building redeveloped and tenants cannot oppose such a demolition. The Krishna Baug building near Malad Railway station was demolished two years ago. (Raju Shinde / HT Photo) The eight tenants had opposed their eviction and the demolition of the 100-year-old Krishna Baug Building No.1 which had been classified by the Brihanmumbai Municipal Corporation (BMC) as a C1 category building, extremely dangerous and unfit for habitation. In 2020 the BMC had issued a notice for the building's immediate demolition. A division-bench of justices Ajey Gadkari and Kamal Khata heard two separate pleas, one by the tenants of commercial premises filed in 2023, challenging the BMC's demolition notice and questioning the C1 category, and another by building owners asking for the demolitions to be enforced, instead of being stalled by tenants. Tenants wanted the building to be reclassified from the C1 category to the C2-B category which suggests repairs and renovations. They said that repair work had already been completed, the ground floor of the building was no longer dangerous, and there was no need for evicting them anymore. The court called this as an 'obstructionist approach intended to hinder the landlord's efforts toward redevelopment' and made it illegal for tenants to obstruct demolitions. The court added that the rights of tenants are safeguarded by the Maharashtra Rent Control Act, 1999 and the BMC Act. The court said that as per section 17 (tenants rights in matters of redevelopment) of the Rent Control Act, and section 499 (regarding repair work) and 354 (removal of structures) of the BMC Act, tenants had the right to oppose the 'reconstruction' of the building, but not the 'redevelopment' of it. In real estate, reconstruction refers to rebuilding a structure without any change, and redevelopment involves demolishing the structure and building a new one with a different design and layout. While asking the tenants to pay the fine, the court said that they had been focused only on extending their stay in the building without taking into consideration other residents of the building.
The Hindu
8 hours ago
- The Hindu
Lab-grown diamond jewellery start-up Aukera raises $15 million, to expand network
Lab-grown diamond jewellery company Aukera on Monday said it has raised $15 million in growth capital led by Peak XV Partners with follow-on participation from existing investors, including Fireside Ventures, Sparrow Capital, Prath Ventures and Alteria Capital. The investment will accelerate its retail expansion plans and contribute to enhancing product offerings, Aukera said in a release. It has stores in Bengaluru, Delhi NCR and Hyderabad and expanding into new cities. The brand will scale into a Rs.1,000 crore brand in next 5-7 years', founder and CEO Lisa Mukhedkar said.
